Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.0150 (0.14%) ($27.4300 - $28.2000) on Thu. Sep. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 52 | Latest Price | $28.0150(0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -1.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(48%) IWC(45%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.165% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) EDOC(-4%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $27.66(1.28%) | 10 Day Moving Average | $27.62(1.43%) | 20 Day Moving Average | $27.96(0.2%) | To recent high | -5.4% | To recent low | 19.3% | Market Cap | $3.829b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |